Hear from the experts in the field of early-stage breast cancer on the performance and utility of the Prosigna® breast cancer prognostic gene signature in this webinar. From current to emerging treatment options, the speaker panel will discuss different biomarker strategies that support shared decision-making for the management of hormone-receptor positive (HR+) patients.
Download the speakers’ presentations here:
